Instant Report

Date: 06-Nov-2020

Indian Firm Signs MoU With Bangladesh Government For Anti Covid Vaccine Production

Serum Institute of India, a Pune-based vaccine manufacturing major has entered into a tripartite MoU with Government of Bangladesh and Bangladesh company Beximco to supply 30 million doses of the COVID-19 vaccine. The MoU was signed on November 05, 2020 in Dhaka in the presence of Bangladesh Health Minister Zahed Maleque.

Thé MoU will facilitate vaccination of 15 million people. Serum Institute will be manufacturing 5 million doses per month for supplying to Bangladesh.

Serum Institute of India has taken on the development of Oxford University's potential COVID-19 vaccine, scoring billions in funding and signing multiple deals to supply over three billion doses to countries around the world. Data in October showed the vaccine produces an immune response in both old and young adults. AstraZeneca is expected to publish eagerly awaited late-stage clinical trial data in the coming weeks.India produces over 60% of the world’s vaccine. There is no way that it will not take into account Bangladesh’s requirements in view of the strategic ties. In fact, Prime Minister Modi has directed that india should not limit its efforts to its immediate neighbourhood but also reach out to the entire world in providing vaccines, medicines and IT platforms for the vaccine delivery system.


India had already mentioned that Bangladesh will be accorded priority whenever the vaccine was ready for use. External Affairs Minister Dr S Jaishankar had reiterated India’s readiness to cooperate on vaccines to his Bangladesh counterpart Dr AK Abdul Momen during the Joint Consultative Commission meeting between both the countries on September 29, 2020.

During his August 2020 visit to Dhaka, Foreign Secretary Harsh Vardhan Shringla had briefed Prime Minister Sheikh Hasina about India’a efforts towards vaccine development. He informed that the testing for the three vaccines was in different stages and that India would launch a massive production exercise once concurrence was received from its scientific community. India is trying that these vaccines available to each and every person within the shortest possible time.

India had already provided Covid-related assistance to Bangladesh in three tranches and has been also conducting capacity building courses for the medical professionals in Bangladesh